[SARS-CoV-2 infection (COVID-19): what can we expect?] / SARS-CoV-2-Infektion (COVID-19): Was kommt auf uns zu?
Dtsch Med Wochenschr
; 145(11): 740-746, 2020 Jun.
Article
in German
| MEDLINE | ID: covidwho-535976
ABSTRACT
- Case numbers in China are clearly declining, case numbers in many European regions are no longer increasing exponentially.- Data on mortality from SARS-CoV-2 infection are contradictory; mortality is certainly lower than for SARS and MERS, but probably higher than for most seasonal flu outbreaks in recent years- The main complication of SARS-CoV-2 infection is pneumonia with development of acute respiratory distress syndrome (ARDS)- Asymptomatic and oligosymptomatic courses with virus shedding are not uncommon; they may be more frequent in children than in adults. Virus excretion in asymptomatic people and in the pre-symptomatic phase of an infection is relevant for transmission- An effective antiviral therapy has not yet been established. Steroids for anti-inflammatory therapy are not recommended- It is very important to prepare all actors in the health care system for a longer-term burden of inpatients and complications and to create the necessary capacities. Low-threshold diagnostic testing and rapid detection of infection chains remain essential for better control of the pandemic. An effective vaccine is urgent.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Pandemics
Type of study:
Diagnostic study
/
Observational study
Topics:
Long Covid
/
Vaccines
Limits:
Humans
Language:
German
Journal:
Dtsch Med Wochenschr
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS